US/UK/Canada

Share

Pick a time period -
Tags ( Active)

Clinical progress of Follicum’s lead candidate FOL-005 for hair growth presented at the world's largest hair conference

Follicum AB ("Follicum" or "The Company") today announces that a poster entitled "FOL-005 - modulation of hair growth in clinical studies" will be presented at the 11thWorld Congress for Hair Research scientific conference in Barcelona, April 24-27, 2019. This conference is one of the most important in the field bringing together the world's leading researchers and aims to further develop scientific knowledge and understanding of hair growth factors, hair and scalp diseases and their treatment.The poster will, present the results of the two clinical studies carried out in collaboration with

Follicum presents diabetes research at Bio-Europe in Copenhagen

Follicum AB ("Follicum" or the Company") today announces that the Company will present results from their diabetes research during the session ”Is the ecosystem of translational metabolic research in greater Copenhagen sustaining a competitive biotech industry?” November 7. The meeting starts with a panel debate lead by Thomas Landh from Novo Nordisk followed by a  ”Showcase Session” where Follicum will present results from their diabetes research.Follicum initially identified a new class of peptides that increase insulin secretion in several experimental models. A number of new peptides

Presentation of Follicum at LSX Nordic Congress 30 August 2018

Follicum's CEO Jan Alenfall presented the company at LSX Nordic Congress in Stockholm 30 August 2018.See the presentation  For further information, please contact:Jan Alenfall – CEO, Follicum ABTelephone: +46 (0)46 - 19 21 97Email: info@follicum.com About Follicum ABFollicum is a biotech company focused on the discovery and development of peptide-based drugs. The primary focus is in hair growth stimulation, where Follicum has obtained very promising results with FOL-005 in a recently completed clinical trial.

Follicum will present FOL-005 at the scientific conference European Hair Research Society, 18-20 May 2018

Follicum AB (“Follicum” or “the Company”) today announces that CEO Jan Alenfall will give a presentation of the development of FOL-005 at the conference European Hair Research Society, which takes place in Bologna, Italy, 18-20 May 2018.The presentation will be included in the part of the conference that will discuss cell-based, growth-factor-based and pharmaceutical treatments. Follicum will also present a poster with the title “FOL-005 – a novel peptide drug regulates hair growth in a Phase I/IIa study” at the same conference. Information about the poster and the scientific program:

There are no items matching the current filter
There are no more items matching the current filter
Back to top